TRIM29 and small cell lung carcinoma: Similar to genetic or pharmacological inhibition of CARM1 and ablation of NFIB methylation, we observed reduced tumorigenic capacity of SCLC cells upon TRIM29 deletion (Supplementary Fig. 3f, g).